MBBS OSCE · General Medicine / Neurology

Epilepsy — pre-conception counselling OSCE station (NEET-PG/INICET)

An MBBS OSCE station testing pre-conception counselling of a woman with epilepsy on valproate: medication switch (avoid valproate, change to levetiracetam or lamotrigine), folic acid, monotherapy lowest dose, contraception interactions, lamotrigine-level monitoring in pregnancy, breastfeeding, the MHRA Pregnancy Prevention Programme, and driving. Assesses safe prescribing and clear communication.

10 min stationVerification in progress
On this page
Study tools

Exam tags

NEET-PGINICET

Candidate instructions

You are the doctor in the medicine clinic. A 27-year-old woman with idiopathic generalised epilepsy, seizure-free for 4 years on sodium valproate 1000 mg twice daily, wishes to conceive. She takes the combined oral contraceptive pill and holds a driving licence. You have 8 minutes to assess and counsel her, and 2 minutes for examiner questions.

Candidate tasks

  1. Take a focused epilepsy history — syndrome/seizure type, seizure freedom duration, current and past drugs, side effects, and an obstetric/family history.
  2. Identify and explain the risks of continuing valproate in pregnancy.
  3. Outline a pre-conception medication plan and the rationale for each change.
  4. Address contraception, driving, and pregnancy-related monitoring.
  5. Communicate clearly and empathetically, check understanding, and provide a safety-net and follow-up plan.

Examiner checklist (mark each as done / partial / not done)

  • Recognises this is idiopathic generalised epilepsy and that valproate must be changed before conception because it is teratogenic and impairs cognitive outcome at 3 years (NEJM fetal-AED study).[1]
  • Names an appropriate alternative: levetiracetam or lamotrigine, introduced carefully before conception, ideally as monotherapy at the lowest effective dose.[1][2]
  • States that lamotrigine must be titrated slowly (and more cautiously with valproate) to avoid Stevens-Johnson syndrome, and that lamotrigine clearance rises in pregnancy so levels are monitored and the dose titrated up, then reduced postpartum.[2]
  • Prescribes high-dose folic acid 5 mg daily, started before conception and continued through pregnancy.[1]
  • Explains that abrupt withdrawal of all medication is dangerous (recurrence / status epilepticus); the switch must be planned and supervised.
  • Addresses contraception: an enzyme-inducing AED reduces the efficacy of the combined pill — she may need a higher-dose or alternative (e.g. progesterone-only or long-acting) method during the transition.
  • States the MHRA valproate Pregnancy Prevention Programme principle: valproate is contraindicated in pregnancy unless strict criteria (no alternatives, highly effective contraception, annual specialist review) are met.
  • Counsels that breastfeeding is generally encouraged (benefits usually outweigh small drug exposure) and discusses the driving rule (must remain seizure-free; India RTO typically >=1 year seizure-free for a private licence).
  • Arranges specialist (neurology) and obstetric/antenatal follow-up, a pre-conception plan in writing, and a safety-net to report any seizures.

Model answer / expected standard

This woman has well-controlled idiopathic generalised epilepsy but is on valproate, which is teratogenic and associated with reduced IQ at 3 years after in-utero exposure. The plan is to switch her pre-conception to levetiracetam or lamotrigine as monotherapy at the lowest effective dose, ensuring seizure control is maintained before she conceives — abrupt drug withdrawal is dangerous. Lamotrigine is titrated slowly (Stevens-Johnson risk) and its level monitored in pregnancy (clearance rises). She should start folic acid 5 mg daily before conception. Her combined pill may be less effective during the transition if an enzyme-inducing drug is used, so contraception must be reviewed. Once stable, pregnancy is managed jointly with neurology and obstetrics; breastfeeding is usually encouraged. Valproate must not be used in pregnancy outside the MHRA Pregnancy Prevention Programme. Driving is allowed provided she remains seizure-free (typically >=1 year for a private licence).[1][2]

Common errors

  • Leaving the patient on valproate into pregnancy, or stopping all drugs abruptly.
  • Starting lamotrigine too fast (Stevens-Johnson syndrome), especially combined with valproate.
  • Forgetting folic acid 5 mg pre-conception.
  • Not warning that an enzyme-inducing AED reduces contraceptive efficacy.
  • Not monitoring lamotrigine levels in pregnancy (clearance rises; seizures may recur).
  • Failing to arrange joint neurology-obstetric follow-up.

References

The station is built on the NEJM fetal-antiepileptic-drug study of cognitive outcome at 3 years and the Continuum overview of epilepsy and its revised classification.[1][2]

References2Show
  1. [1]Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. New England Journal of Medicine, 2009.PMID 19369666
  2. [2]Pack AM. Epilepsy Overview and Revised Classification of Seizures and Epilepsies. Continuum (Minneapolis, Minn.), 2019.PMID 30921011
Epilepsy — pre-conception counselling OSCE station (NEET-PG/INICET) · MBBS OSCE · NeetVellum